Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDillistone Regulatory News (DSG)

Share Price Information for Dillistone (DSG)

Share Price is delayed by 15 minutes
Get Live Data
11.50    0.00 (0.00%)
Bid:
11.00
Ask:
12.00
Spread: 1.00 (9.091%)
Market Cap: £4.07m
DSG Live PriceLast checked at - London Stock Exchange

Intraday Dillistone Share Chart

Issue of Options

16 Jun 2022 08:00

RNS Number : 1119P
Dillistone Group PLC
16 June 2022
Β 

Β 

Dillistone Group Plc("Dillistone", the "Company" or the "Group") Issue of OptionsΒ 

Dillistone Group Plc, the AIM quoted supplier of software and services to recruiters, announces the grant on 16 June 2022 of options over 570,000 Ordinary Shares of 5p each in Dillistone (the "Options") to certain of its Directors and other members of staff.

Options over 500,000 Ordinary Shares were granted, exercisable within 3 to 10 years but subject to performance conditions, to five Directors under the Company's LTIP scheme with an exercise price of 22.5p per share. Details of the grants to Directors are set out below. The remuneration committee has approved the grant of options and the thresholds which are challenging.

Status

LTIP option grantΒ at 22.5p

No. Options held post Grant including Savings Related Share Options

Current Shareholdingin Company

Jason Starr

Director

100,000

150,000

3,577,591

Simon Warburton

Director

100,000

166,250

77,290

Paul Mather

Director

100,000

217,500*

82,177

Steve Hammond

Director

100,000

191,250

0

Ian Mackin

Director

100,000

131,250

0

Total

500,000

856,250

3,737,058

* Paul Mather's interest includes options over 51,250 shares granted to his spouse as an employee.

In addition, options over 70,000 Ordinary Shares with an exercise price of 22.5p per share were granted, exercisable within 3 to 10 years but without performance conditions, to other members of staff.

Following this grant, the Company has 1,819,725 Ordinary Shares under option, representing 9.25% of the current issued share capital of the Company.

Commenting on the grant, Giles Fearnley, Non Executive Chairman at Dillistone said: "This grant of options is to incentivise staff as the Group focuses on returning to profitability and continued growth in our Talentis product."

This announcement contains inside information for the purposes of Article 7 of EU Regulation 596/2014.

Contacts:

Β 

Dillistone Group Plc

Β Via Walbrook PR

Jason Starr

Chief Executive

Ian Mackin

Interim Finance Director

WH Ireland Limited (Nominated adviser)

Chris Fielding

Head of Corporate Finance

020 7220 1650

Walbrook PR

Tom Cooper / Nick Rome

020 7933 8780

dillistone@walbrookpr.com

Β 

Notes to Editors:

Β 

Dillistone Group Plc is a global leader in the supply of technology solutions and test & train services to the recruitment sector worldwide, in both contingency recruitment and executive search markets.

Β 

The Group trades through the Ikiru People brand (www.IkiruPeople.com), selling into recruitment, staffing and executive search businesses, as well as corporate talent acquisition teams around the world.

Β 

Ikiru People provides the platforms its clients need to test and train candidates, support further development, enhance the recruitment process, and source the best talent. Operating in more than 50 countries over six continents and working with thousands of users, the Group boasts more than 30 years in the market and 100's of years of collective experience.Β 

Β 

The Group develops, markets and supports the Talentis, FileFinder, Infinity, Mid-Office, ISV and GatedTalent products.

Β 

Dillistone was admitted to AIM, a market operated by the London Stock Exchange plc, in June 2006.Β 

Β 

Learn about our products:

Β 

Talentis Software: https://www.talentis.global/recruitment-software

Voyager Software: https://www.voyagersoftware.com

GatedTalent Services: https://www.talentis.global/optimization-services

Β 

Β 

Β 

1.

Details of the person discharging managerial responsibilities/person closely associated

a)

Name:

1) Jason Starr

2) Simon Warburton

3) Paul Mather

4) Steve Hammond

5) Ian Mackin

2.

Reason for the notification

a)

Position/status:

1) Chief Executive Officer

2) Chief Technology Officer

3) Chief Operating Officer

4) Group Engineering Officer

5) Interim Finance Director

b)

Initial notification/Amendment:

Initial notification

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name:

Dillistone Group Plc

b)

LEI:

213800E9K3JGQ46ZS753

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument:

Identification code:

Ordinary shares of 5 pence each

Β 

ISIN Code: GB00B13QQB40

b)

Nature of the transaction:

Grant of Options over Ordinary Shares

c)

Price(s) and volume(s):

Price(s)

Volume(s)

1)

2)

3)

4)

5)

100,000

100,000

100,000

100,000

100,000

d)

Aggregated information:

Β· Aggregated volume:

Β· Price:

Β 

Β 

Β 

e)

Date of the transaction:

16 June 2022

f)

Place of the transaction:

Outside a trading venue

Β 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Β 
END
Β 
Β 
DSHGLGDLLGBDGDL
Date   Source Headline
7th May 20267:00 amRNSFinal Results & Investor Presentation
24th Apr 20267:00 amRNSNotice of Final Results & Investor Presentation
9th Mar 20262:44 pmRNSHolding(s) in Company
9th Mar 20262:44 pmRNSHolding(s) in Company
9th Mar 20262:23 pmRNSHolding(s) in Company
9th Mar 20262:23 pmRNSHolding(s) in Company
2nd Mar 20263:08 pmRNSHolding(s) in Company
25th Feb 202611:40 amRNSHolding(s) in Company
25th Feb 202610:09 amRNSHolding(s) in Company
23rd Feb 20262:28 pmRNSResult of GM & Directorate Change
11th Feb 202612:59 pmRNSHolding(s) in Company
5th Feb 202611:28 amRNSResult of Placing and Subscription
4th Feb 20264:47 pmRNSProposed Placing and Subscription
30th Sep 20257:00 amRNSInterim Results & Investor Presentation
11th Sep 20257:00 amRNSNotice of Interim Results & Investor Presentation
4th Jun 202511:50 amRNSResult of AGM
4th Jun 20257:01 amRNSAGM Statement
4th Jun 20257:00 amRNSRelated party loan
9th May 202511:32 amRNSDirectorate Declaration
8th Apr 20257:00 amRNSFinal Results & Investor Presentation
3rd Apr 20257:00 amRNSNotice of Results & Investor Presentation
5th Feb 20257:00 amRNSTrading Update & Notice of Results
4th Dec 20247:00 amRNS-ROpenAI powered Interview Simulation Platform
17th Sep 20247:00 amRNSInterim Results & Investor Presentation
11th Sep 20247:00 amRNSNotice of Results & Investor Presentation
2nd Sep 20249:45 amRNSHolding(s) in Company
29th Aug 20248:30 amRNSHolding(s) in Company
23rd Aug 20247:00 amRNSTrading update and Fund Raising
15th Jul 20247:00 amRNSChange of Adviser
12th Jun 20241:40 pmRNSResult of AGM
12th Jun 20247:00 amRNSAGM Statement
25th Apr 20247:00 amRNSFinal Results & Investor Presentation
22nd Apr 20247:00 amRNSNotice of Results & Investor Presentation
9th Apr 20247:00 amRNSBlock listing Interim Review
30th Jan 20247:00 amRNSTrading Update & Notice of Results
9th Oct 20237:00 amRNSBlock listing Interim Review
26th Sep 20237:00 amRNSInterim Results & Investor Presentations
18th Sep 20237:00 amRNSNotice of Results & Investor Presentations
13th Jun 20231:18 pmRNSResult of AGM
13th Jun 20237:00 amRNSAGM Statement
25th Apr 20237:00 amRNSFinal Results & Investor Presentation
11th Apr 20237:00 amRNSBlock listing Interim Review
30th Mar 20237:00 amRNSContract & Notice of Results
2nd Feb 20237:00 amRNSTrading Update & Notice of Results
7th Nov 20227:00 amRNSDirector Dealings
10th Oct 20227:00 amRNSBlock listing Interim Review
26th Sep 20227:01 amRNSDirectorate Changes
26th Sep 20227:00 amRNSInterim Results & Investor Presentation
20th Sep 20227:00 amRNSNotice of Results & Investor Presentation
16th Jun 20228:00 amRNSIssue of Options

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.